 VALENCIA, Calif. and MELBOURNE, Australia, Feb. 11, 2021 GLOBE NEWSWIRE -- AVITA Medical, Inc. NASDAQ: RCEL, ASX:AVH Company, a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today reported financial results for its second quarter of fiscal year 2021, ended December 31, 2020. 